/Investor DB

APERTURE Venture Partners — 2011 Investments

2 investments dated 2011 · listed companies and verified rows first · show all

Avedro, Inc.avedro.comin𝕏Series C · Jul 2011 · $25Macquired by Glaukos

Avedro is an ophthalmic company focused on corneal health, known for bio-activated cross-linking therapies such as the KXL system and riboflavin-based treatments used to address progressive keratoconus.

BiotechHealthtechMedical DevicesWaltham, US

David F. Muller(Executive Officer, Director)inBrian J. Roberts(Executive Officer)inRhonda J. Bracey(Executive Officer)inThomas W. Burns(Chairman & Chief Executive Officer)

BoardJason Hong(Director)Jeff Dykan(Director)in

Co-investorsLAVLilly Asia VenturesSCP Vitalife PartnersThird Point VenturesWestern Technology InvestmentAbingworth+5 more

Xlumenaxlumena.cominSeries B · Apr 2011 · $7M

HealthtechMountain View, US

Kenneth Binmoeller, M.D.(Executive Officer, Director)inGreg Patterson(Executive Officer, Director)

BoardA. Barr Dolan(Director)Eric Sillman(Director)Anthony Natale, M.D.(Director)Avi Kometz(Director)

Co-investorsATEL VenturesThird Point VenturesAscent Biomedical VenturesDeerfield Management CompanyThird PointWestern Technology Investment

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.